Viewing Study NCT06259669


Ignite Creation Date: 2025-12-24 @ 10:55 PM
Ignite Modification Date: 2025-12-28 @ 2:58 AM
Study NCT ID: NCT06259669
Status: RECRUITING
Last Update Posted: 2025-12-11
First Post: 2024-02-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study to Compare Maternal, Fetal, and Infant Outcomes of Women With Mild to Moderate Atopic Dermatitis Exposed to Ruxolitinib Cream During Pregnancy With an Unexposed Control Population
Sponsor: Incyte Corporation
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module